89 related articles for article (PubMed ID: 12687260)
1. Analysis of the interferon status and cytokine profile in patients with genital herpes.
Mezentseva MV; Narovlyansky AN; Scherbenko VE; Polonsky VO; Anokhina EY; Ershov FI
Russ J Immunol; 2002 Jul; 7(2):167-74. PubMed ID: 12687260
[TBL] [Abstract][Full Text] [Related]
2. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
3. [Use of interferon inducers for pharmacological correction of cytokine disturbances in patients with recurrent genital herpes].
Shperling IA; Vengerovskiĭ AI; Shperling NV
Eksp Klin Farmakol; 2010 Aug; 73(8):39-42. PubMed ID: 20919558
[TBL] [Abstract][Full Text] [Related]
4. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection.
Svensson A; Bellner L; Magnusson M; Eriksson K
J Reprod Immunol; 2007 Jun; 74(1-2):114-23. PubMed ID: 17092567
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
Braun RP; Payne LG; Dong L
Virol J; 2006 Jul; 3():54. PubMed ID: 16822314
[TBL] [Abstract][Full Text] [Related]
6. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
7. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
8. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
[TBL] [Abstract][Full Text] [Related]
10. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
11. Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia.
Seppanen M; Meri S; Notkola IL; Seppala IJ; Hiltunen-Back E; Sarvas H; Lappalainen M; Valimaa H; Palikhe A; Valtonen VV; Lokki ML
J Infect Dis; 2006 Sep; 194(5):571-8. PubMed ID: 16897653
[TBL] [Abstract][Full Text] [Related]
12. Acceptance and outcome of herpes simplex virus type 2 antibody testing in patients attending an STD clinic--recognized and unrecognized infections.
Löwhagen GB; Berntsson M; Bonde E; Tunbäck P; Krantz I
Acta Derm Venereol; 2005; 85(3):248-52. PubMed ID: 16040412
[TBL] [Abstract][Full Text] [Related]
13. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.
Morrow R; Friedrich D
Clin Microbiol Infect; 2006 May; 12(5):463-9. PubMed ID: 16643524
[TBL] [Abstract][Full Text] [Related]
14. An update on short-course episodic and prevention therapies for herpes genitalis.
Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
[TBL] [Abstract][Full Text] [Related]
15. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
16. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-21 mRNA expression during virus infections.
Holm C; Nyvold CG; Paludan SR; Thomsen AR; Hokland M
Cytokine; 2006 Jan; 33(1):41-5. PubMed ID: 16406655
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Methylenedioxymethamphetamine increases susceptibility to genital herpes simplex virus infection in mice.
Pennock JW; Stegall R; Bubar MJ; Milligan G; Cunningham KA; Bourne N
J Infect Dis; 2009 Oct; 200(8):1247-50. PubMed ID: 19758099
[TBL] [Abstract][Full Text] [Related]
20. Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells.
Danke NA; Koelle DM; Kwok WW
Hum Immunol; 2005 Jul; 66(7):777-87. PubMed ID: 16112025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
